Andrey Khramtsov - Concepedia

Author

Andrey Khramtsov

Also Known As

A I Khramtsov, A Khramtsov, A. I. Khramtsov, A. Khramtsov, AI Khramtsov, Andrey I Khramtsov, Andrey I. Khramtsov, Andrey Ilyich Khramtsov, Andrey Khramtsov

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of Chicago Cancer Genetics (United States)University of North Carolina at Chapel Hill University of Chicago Medical Center University of Alabama at Birmingham

About

Andrey Khramtsov is an author at University of Chicago specializing in medicine, tumor biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.1K
2	Cell Biology	7	7	663
3	Public Health	1	1	20
4	Biomolecular Engineering	1	1	38
5	Endocrinology	1	1	18

Andrey Khramtsov

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Jason I. Herschkowitz, Karl Simin, Victor Weigman, Genome biology	2007	1.3K
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome Andrey Khramtsov, Galina Khramtsova, Maria Tretiakova, American Journal Of Pathology Tumor BiologyRadiation OncologyBasal-like Breast CancersOncologySignaling Pathway	2010	507
Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer Dezheng Huo, Francis Ikpatt, Andrey Khramtsov, Journal of Clinical Oncology	2009	366
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome Michael J. Campbell, Nathan Tonlaar, Elisabeth R. Garwood, Breast Cancer Research and Treatment Breast OncologyMedicinePoor Clinical OutcomeImmunologyPathology	2010	260
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression Sujun Hua, Caleb B. Kallen, Ruby Dhar, Molecular Systems Biology Histone ModificationsChromatinVariant H2a.zChromatin RemodelingEpigenetic Change	2008	180
Survivin-Driven and Fiber-Modified Oncolytic Adenovirus Exhibits Potent Antitumor Activity in Established Intracranial Glioma Ilya V. Ulasov, Zeng B. Zhu, Matthew A. Tyler, Human Gene Therapy	2007	124
A Selective Small Molecule Inhibitor of c-Met, PHA665752, Inhibits Tumorigenicity and Angiogenesis in Mouse Lung Cancer Xenografts Neelu Puri, Andrey Khramtsov, Salman Ahmed, Cancer Research	2007	123
Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer Loren K. Mell, Jeffrey Meyer, Maria Tretiakova, Clinical Cancer Research	2004	85
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo Ilya V. Ulasov, Adam M. Sonabend, Sumon Nandi, British Journal of Cancer	2009	70
Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution Brooke E. Sylvester, Dezheng Huo, Andrey Khramtsov, Clinical Cancer Research	2011	65

Page 1